NewAmsterdam Pharma Company N.V. (NAMSW)Naarden, Netherlands | NasdaqGM
23.11 USD
-0.92
(-3.849%) ⇩
(April 17, 2026, 9:56 a.m.
EDT)
Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:22 a.m. EDT
Near-term momentum reversal confirms the 45-day forecast model's bearish direction; with revenue contraction of -99.8% and severe negative margins, the instrument faces fundamental deterioration and should be avoided for both immediate and long-term horizons. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.113603 |
| AutoETS | 0.117660 |
| AutoARIMA | 0.117798 |
| MSTL | 0.131215 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 63% |
| H-stat | 1.75 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.108 |
| Excess Kurtosis | -1.41 |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 0.03 |
| Revenue per Share | 0.19 |
| Beta | 0.13 |
| Website | https://www.newamsterdampharma.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 1.7978208 |
| Address1 | Gooimeer 2-35 |
| All Time High | 29.99 |
| All Time Low | 0.06 |
| Ask | 0.0 |
| Ask Size | 0 |
| Average Daily Volume10 Day | 1,050 |
| Average Daily Volume3 Month | 1,043 |
| Average Volume | 1,043 |
| Average Volume10Days | 1,050 |
| Beta | 0.131 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 5.974 |
| City | Naarden |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Netherlands |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 23.11 |
| Current Ratio | 7.876 |
| Custom Price Alert Confidence | HIGH |
| Day High | 23.11 |
| Day Low | 22.28 |
| Debt To Equity | 0.03 |
| Display Name | NewAmsterdam Pharma Company |
| Ebitda | -225,463,008 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 21.6962 |
| Fifty Day Average Change | 1.4138012 |
| Fifty Day Average Change Percent | 0.065163545 |
| Fifty Two Week Change Percent | 179.78207 |
| Fifty Two Week High | 29.99 |
| Fifty Two Week High Change | -6.879999 |
| Fifty Two Week High Change Percent | -0.22940978 |
| Fifty Two Week Low | 7.155 |
| Fifty Two Week Low Change | 15.955 |
| Fifty Two Week Low Change Percent | 2.2299092 |
| Fifty Two Week Range | 7.155 - 29.99 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,612,967,400,000 |
| Float Shares | 71,466,423 |
| Free Cashflow | -112,909,872 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 100 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 22,503,000 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,022-11-23 |
| Language | en-US |
| Long Business Summary | NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands. |
| Long Name | NewAmsterdam Pharma Company N.V. |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_685404834 |
| Net Income To Common | -203,819,008 |
| Open | 24.41 |
| Operating Cashflow | -147,783,008 |
| Operating Margins | -2,061.875 |
| Phone | 31 35 206 2971 |
| Previous Close | 24.035 |
| Price Hint | 2 |
| Price To Book | 3.86843 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.686 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.92499924 |
| Regular Market Change Percent | -3.8485513 |
| Regular Market Day High | 23.11 |
| Regular Market Day Low | 22.28 |
| Regular Market Day Range | 22.28 - 23.11 |
| Regular Market Open | 24.41 |
| Regular Market Previous Close | 24.035 |
| Regular Market Price | 23.11 |
| Regular Market Time | 1,776,434,180 |
| Regular Market Volume | 1,150 |
| Return On Assets | -0.17266001 |
| Return On Equity | -0.2829 |
| Revenue Growth | -0.998 |
| Revenue Per Share | 0.19 |
| Sand P52 Week Change | 0.38150132 |
| Sector | |
| Sector Key | |
| Short Name | NewAmsterdam Pharma Company N.V |
| Source Interval | 15 |
| Symbol | NAMSW |
| Total Cash | 636,241,024 |
| Total Cash Per Share | 5.534 |
| Total Debt | 202,000 |
| Total Revenue | 22,503,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 20.05254 |
| Two Hundred Day Average Change | 3.0574608 |
| Two Hundred Day Average Change Percent | 0.1524725 |
| Type Disp | Equity |
| Volume | 1,150 |
| Website | https://www.newamsterdampharma.com |
| Zip | 1,411 DC |